fda glp-1 warning news november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of GLP-1 Weight-Loss Drug Demonstration Begins

patent describes new glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of diabetes type 2, hyperglycemia and obesity.

Sharing what this could mean for you.

muscle), in addition to seeing improvements in glycaemic control10

Dual-action peptides support obesity & appetite studies

Recently, multiple case reports and studies indicating safety risks for these medications and their use in patients planning to undergo general anesthesia have been published, as retained gastric contents can lead to intraoperative aspiration

Learn why it happens, proven relief strategies, diet changes, and when to talk to your doctor.